Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80017782 | 8001778 | 2 | F | 20101230 | 20160823 | 20110622 | 20160929 | EXP | US-ROCHE-783400 | ROCHE | 41.75 | YR | M | Y | 0.00000 | 20160929 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80017782 | 8001778 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | CYCLE (28 DAYS): OVER 30-90 MINUTES ON DAY 1 AND 15, LAST DOSE RECEIVED ON 20 DECEMBER 2010. | D | 125085 | 10 | MG/KG | SOLUTION FOR INFUSION | ||||||
| 80017782 | 8001778 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | D | 125085 | 1380 | MG | SOLUTION FOR INFUSION | |||||||
| 80017782 | 8001778 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | D | 125085 | 1360 | MG | SOLUTION FOR INFUSION | |||||||
| 80017782 | 8001778 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | D | 125085 | 680 | MG | SOLUTION FOR INFUSION | |||||||
| 80017782 | 8001778 | 5 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | CYCLE 28 DAYS ON 1, 8, 15, 22 | D | 0 | 25 | MG | |||||||
| 80017782 | 8001778 | 6 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | D | 0 | 50 | MG | ||||||||
| 80017782 | 8001778 | 7 | SS | AVE5026 (LMWT HEPARIN) | SEMULOPARIN SODIUM | 1 | Unknown | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 80017782 | 8001778 | 1 | Malignant neoplasm of islets of Langerhans |
| 80017782 | 8001778 | 5 | Malignant neoplasm of islets of Langerhans |
| 80017782 | 8001778 | 7 | Malignant neoplasm of islets of Langerhans |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 80017782 | 8001778 | DE |
| 80017782 | 8001778 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 80017782 | 8001778 | Blood bilirubin increased | |
| 80017782 | 8001778 | Hypoglycaemia | |
| 80017782 | 8001778 | Sudden death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 80017782 | 8001778 | 1 | 20101020 | 0 | ||
| 80017782 | 8001778 | 2 | 20101020 | 0 | ||
| 80017782 | 8001778 | 3 | 20101122 | 0 | ||
| 80017782 | 8001778 | 4 | 20101220 | 0 | ||
| 80017782 | 8001778 | 5 | 20101020 | 0 | ||
| 80017782 | 8001778 | 6 | 20101020 | 20101025 | 0 |